Home » Cancer Drugmaker TetraLogic Pharma Raises $32 Million
Cancer Drugmaker TetraLogic Pharma Raises $32 Million
TetraLogic Pharmaceuticals has completed a $32 million Series C fund-raise that the company will use to push its cancer drug through a Phase IIa study.
MedCity News
MedCity News
Upcoming Events
-
07May
-
14May
-
30May